Generalization of Extinction Learning
NCT01900301
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Social Anxiety Disorder
Interventions
DRUG:
Scopolamine
DRUG:
intranasal placebo
Sponsor
University of California, Los Angeles